Consultation Documents (11th November - 24th November 2009)
NICE are now consulting on the following documents:
Delirium: draft guideline consultation - closing date for comments is 6th January 2010
Chronic myeloid leukaemia: dasatinib and nilotinib: appraisal consultation document - closing date for comments is 7th December 2009
Crohn's disease: infliximab (review) and adalimumab: appraisal consultation document - closing date for comments is 10th December 2009
Weight management after childbirth (consultation on the evidence) - closing date for comments is 17th November 2009
Hepatocellular carcinoma (advanced and metastatic): sorafenib (first line): final appraisal determination - closing date for comments is 3rd December 2009
Skin cancer (update): consultation on the draft guidance - closing date for comments is 21st December 2009
Ultrasound guided transbronchial biopsy for peripheral lung lesions (interventional procedures consultation) - closing date for comments is 21st December 2009
Endoscopic submucosal dissection of lower gastrointestinal lesions (interventional procedures consultation) - closing date for comments is 21st December 2009
Transcatheter endovascular closure of perimembranous ventricular septal defect (interventional procedures consultation) - closing date for comments is 21st December 2009
Arteriovenous crossing sheathotomy for branch retinal veing occlusion (interventional procedures consultation) - closing date for comments is 21st December 2009
Colorectal cancer (metastatic): bevacizumab (appraisal consultation document) - closing date for comments is 14th December 2009
NICE are now consulting on the following documents:
Delirium: draft guideline consultation - closing date for comments is 6th January 2010
Chronic myeloid leukaemia: dasatinib and nilotinib: appraisal consultation document - closing date for comments is 7th December 2009
Crohn's disease: infliximab (review) and adalimumab: appraisal consultation document - closing date for comments is 10th December 2009
Weight management after childbirth (consultation on the evidence) - closing date for comments is 17th November 2009
Hepatocellular carcinoma (advanced and metastatic): sorafenib (first line): final appraisal determination - closing date for comments is 3rd December 2009
Skin cancer (update): consultation on the draft guidance - closing date for comments is 21st December 2009
Ultrasound guided transbronchial biopsy for peripheral lung lesions (interventional procedures consultation) - closing date for comments is 21st December 2009
Endoscopic submucosal dissection of lower gastrointestinal lesions (interventional procedures consultation) - closing date for comments is 21st December 2009
Transcatheter endovascular closure of perimembranous ventricular septal defect (interventional procedures consultation) - closing date for comments is 21st December 2009
Arteriovenous crossing sheathotomy for branch retinal veing occlusion (interventional procedures consultation) - closing date for comments is 21st December 2009
Colorectal cancer (metastatic): bevacizumab (appraisal consultation document) - closing date for comments is 14th December 2009
Interventional Procedures Guideline IPG319. Percutaneous intradiscal electrothermal therapy for low back pain (23rd November 2009)
The National Institute for Health and Clinical Excellence (NICE) has reviewed this guidance, after consultation, which was originally issued in August 2004. The guidance has now been updated and published along with the consultation comments and audit support.
Guidance
Interventional Procedures Guideline IPG318. Bronchoscopic lung volume reduction with airway valves for advanced emphysema (23rd November 2009)
Emphysema is a disease of the lungs in which the walls of the air sacs become weak and disintegrate, leaving behind abnormally large air spaces that stay filled with air even when the person breathes out. The lungs also become less able to get enough oxygen into the blood, so the person can feel tired and breathless.
The aim of lung volume reduction surgery is to limit airflow to the part of the lung that's working least well, so that the effort of breathing can be concentrated on the part of the lung that's working better. The procedure is undertaken via a small flexible camera inserted down the wind pipe and placing small, one-way valves in the airways. A typical procedure involves placing 3-4 valves.
Guidance
Technology Appraisal TA184. Lung cancer (small-cell) - topotecan (25th November 2009)
Oral topotecan is recommended as a possible treatment for people with relapsed small-cell lung cancer if:
Guidance
The National Institute for Health and Clinical Excellence (NICE) has reviewed this guidance, after consultation, which was originally issued in August 2004. The guidance has now been updated and published along with the consultation comments and audit support.
Guidance
Interventional Procedures Guideline IPG318. Bronchoscopic lung volume reduction with airway valves for advanced emphysema (23rd November 2009)
Emphysema is a disease of the lungs in which the walls of the air sacs become weak and disintegrate, leaving behind abnormally large air spaces that stay filled with air even when the person breathes out. The lungs also become less able to get enough oxygen into the blood, so the person can feel tired and breathless.
The aim of lung volume reduction surgery is to limit airflow to the part of the lung that's working least well, so that the effort of breathing can be concentrated on the part of the lung that's working better. The procedure is undertaken via a small flexible camera inserted down the wind pipe and placing small, one-way valves in the airways. A typical procedure involves placing 3-4 valves.
Guidance
Interventional Procedures Guidance IPG320. Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus (25th November 2009)
Keratoconus is a degenerative condition that usually involves both eyes. It affects the shape of the eyeball and causes blurred vision and light sensitivity. Wearing spectacles or contact lenses can help some people who have this condition. Photochemical corneal collagen cross-linkage is an outpatient procedure. First a local anaesthetic is given in the form of eye drops. Then riboflavin (vitamin B2) drops are applied to the eye, and it is exposed to ultraviolet light. This procedure aims to stabilise the outer coating of the eyeball, called the cornea, with the intention of preventing further changes to its shape.
Guidance
Keratoconus is a degenerative condition that usually involves both eyes. It affects the shape of the eyeball and causes blurred vision and light sensitivity. Wearing spectacles or contact lenses can help some people who have this condition. Photochemical corneal collagen cross-linkage is an outpatient procedure. First a local anaesthetic is given in the form of eye drops. Then riboflavin (vitamin B2) drops are applied to the eye, and it is exposed to ultraviolet light. This procedure aims to stabilise the outer coating of the eyeball, called the cornea, with the intention of preventing further changes to its shape.
Guidance
Interventional Procedures Guidance IPG321. Lateral (including extreme, extra and direct lateral) interbody fusion in the lumbar spine (25th November 2009)
As a person gets older, the discs between the back bones that provide support can deteriorate because of wear and tear. Sometimes this causes such severe pain and disability that surgery is considered.
Lateral interbody spinal fusion involves the removal of all, or part, of the damaged disc and the insertion of a supportive structure, together with a fragment of bone from the hip. It aims to join the two back bones together to prevent movement of the painful joint. The procedure is done through a cut in the patient’s side.
Guidance
As a person gets older, the discs between the back bones that provide support can deteriorate because of wear and tear. Sometimes this causes such severe pain and disability that surgery is considered.
Lateral interbody spinal fusion involves the removal of all, or part, of the damaged disc and the insertion of a supportive structure, together with a fragment of bone from the hip. It aims to join the two back bones together to prevent movement of the painful joint. The procedure is done through a cut in the patient’s side.
Guidance
Technology Appraisal TA184. Lung cancer (small-cell) - topotecan (25th November 2009)
Oral topotecan is recommended as a possible treatment for people with relapsed small-cell lung cancer if:
- re-treatment with the previous treatment is not considered appropriate and
- there is a medical reason why they cannot take the combination of cyclophosphamide, doxorubicin and vincristine (CAV)
Guidance
No comments:
Post a Comment